Sector: Healthcare | Industry: Advanced Medical Equipment & Technology |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 100 Domain Drive EXETER NH 03833 |
Tel: | N/A |
Website: | https://vapotherm.com |
IR: | See website |
Key People | ||
Joseph F. Army President, Chief Executive Officer, Director | John Landry Chief Financial Officer, Senior Vice President, Treasurer | Brian D. Lawrence Senior Vice President, Chief Technology Officer |
Business Overview |
Vapotherm, Inc. is a developer and manufacturer of advanced respiratory technology. It develops non-invasive technologies for respiratory support of patients with chronic or acute breathing disorders. It is focused on the care of patients suffering from respiratory distress, whether associated with lung diseases, such as chronic obstructive pulmonary disease, congestive heart failure, pneumonia, asthma, and COVID-19 or other systemic conditions. Its device solutions are focused on High Velocity Nasal Insufflation, which delivers non-invasive ventilatory support to patients by providing heated, humidified, oxygenated air at high velocities through a small-bore nasal interface, and on closed loop control systems, such as its Oxygen Assist Module, designed to automatically maintain a patients pulse oxygen saturation levels within a specified range for a defined period of time. Its digital solutions are focused on remote patient monitoring, using algorithms to predict respiratory episodes. |
Financial Overview |
For the fiscal year ended 31 December 2023, Vapotherm Inc revenues increased 3% to $68.7M. Net loss decreased 49% to $58.2M. Revenues reflect International segment increase of 24% to $17.6M. Lower net loss reflects Impairment of goodwill decrease from $14.7M (expense) to $0K, Sales and marketing - Balancing value decrease of 28% to $29.2M (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$33.89 to -$9.64. |
Employees: | 182 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $105.12M as of Dec 31, 2023 |
Annual revenue (TTM): | $68.67M as of Dec 31, 2023 |
EBITDA (TTM): | -$32.71M as of Dec 31, 2023 |
Net annual income (TTM): | -$58.19M as of Dec 31, 2023 |
Free cash flow (TTM): | -$27.27M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $97.33M as of Dec 31, 2023 |
Shares outstanding: | 6,193,851 as of Feb 15, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |